251 related articles for article (PubMed ID: 985603)
1. Combination effects in chemical carcinogenesis (experimental results).
Schmähl D
Oncology; 1976; 33(2):73-6. PubMed ID: 985603
[TBL] [Abstract][Full Text] [Related]
2. Combination experiments with very low doses of three genotoxic N-nitrosamines with similar organotropic carcinogenicity in rats.
Berger MR; Schmähl D; Zerban H
Carcinogenesis; 1987 Nov; 8(11):1635-43. PubMed ID: 3664955
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the effects of promoting agents on liver and urinary bladder carcinogenesis in rats.
Ito N; Tatematsu M; Nakanishi K; Tsuda H
Carcinog Compr Surv; 1982; 7():133-7. PubMed ID: 7066916
[No Abstract] [Full Text] [Related]
4. Carcinogenicity of methylated derivatives of N-nitrosodiethylamine and related compounds in Sprague-Dawley rats.
Lijinsky W; Taylor HW
J Natl Cancer Inst; 1979 Feb; 62(2):407-10. PubMed ID: 283272
[TBL] [Abstract][Full Text] [Related]
5. Species specificity in nitrosamine carcinogenesis.
Lijinsky W
Basic Life Sci; 1983; 24():63-75. PubMed ID: 6860278
[No Abstract] [Full Text] [Related]
6. [Organotropic carcinogenic effects of 65 various N-nitroso- compounds on BD rats].
Druckrey H; Preussmann R; Ivankovic S; Schmähl D
Z Krebsforsch; 1967; 69(2):103-201. PubMed ID: 4230610
[No Abstract] [Full Text] [Related]
7. [Experimental models of 2-stage carcinogenesis].
Turusov VS
Eksp Onkol; 1985; 7(3):5-12. PubMed ID: 3893973
[TBL] [Abstract][Full Text] [Related]
8. Identification and assessment of tumor-promoting and cocarcinogenic agents: state-of-the-art in vitro methods.
Bohrman JS
Crit Rev Toxicol; 1983; 11(2):121-67. PubMed ID: 6340968
[No Abstract] [Full Text] [Related]
9. [Possible neuropharmacological regulation of chemical carcinogenesis caused by diethylnitrosamine].
Gurkalo VK; Zabezhinskiĭ MA
Farmakol Toksikol; 1978; 41(3):338-42. PubMed ID: 26598
[TBL] [Abstract][Full Text] [Related]
10. [Experimental studies os syncarcinogenesis in esophageal carcinoma].
Gibel W
Arch Geschwulstforsch; 1967; 30(3):181-9. PubMed ID: 4299442
[No Abstract] [Full Text] [Related]
11. Aflatoxins and nitrosamines: cellular interactions and carcinogenesis.
Lijinsky W
N Z Med J; 1968 Jan; 67(426):Suppl:100-10. PubMed ID: 5238933
[No Abstract] [Full Text] [Related]
12. Influence of disulfiram on the organotropy of the carcinogenic effect of dimethylnitrosamine and diethylnitrosamine in rats.
Schmähl D; Krüger FW; Habs M; Diehl B
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Mar; 85(3):271-6. PubMed ID: 131427
[TBL] [Abstract][Full Text] [Related]
13. Lack of effect of selenium on induction of tumors of esophagus and bladder in rats by two nitrosamines.
Lijinsky W; Milner JA; Kovatch RM; Thomas BJ
Toxicol Ind Health; 1989 Jan; 5(1):63-72. PubMed ID: 2718186
[TBL] [Abstract][Full Text] [Related]
14. [Modification of chemical carcinogenesis with adrenergic compounds].
Gurkalo VK; Zabezhinskiĭ MA
Vestn Akad Med Nauk SSSR; 1978; (2):38-42. PubMed ID: 25543
[No Abstract] [Full Text] [Related]
15. [Experimental development of carcinoma in rats caused by N-nitrosopiperidine with vitamin C].
Kessler H; Husemann B; Wagner W; Lowies B
Zentralbl Chir; 1991; 116(10):651-8. PubMed ID: 1927081
[TBL] [Abstract][Full Text] [Related]
16. Carcinogenic effect of N-nitrosoamines related to butyl(4-hydroxybutyl)nitrosoamine in ACI-N rats, with special reference to induction of urinary bladder tumors.
Okada M; Hashimoto Y
Gan; 1974 Feb; 65(1):13-9. PubMed ID: 4363446
[No Abstract] [Full Text] [Related]
17. Carcinogenicity of N-nitroso-3-hydroxypyrrolidine and dose-response study with N-nitrosopiperidine in rats.
Eisenbrand G; Habs M; Schmähl D; Preussmann R
IARC Sci Publ; 1980; (31):657-66. PubMed ID: 7228288
[No Abstract] [Full Text] [Related]
18. Metabolic fate of N, N-dipropylnitrosamine and N, N-diamylnitrosamine in the rat, in relation to their lack of carcinogenic effect on the urinary bladder.
Suzuki E; Okada M
Gan; 1981 Aug; 72(4):552-61. PubMed ID: 7308667
[TBL] [Abstract][Full Text] [Related]
19. Quantitative aspects of drug-mediated tumour promotion in liver and its toxicological implications.
Kunz W; Schaude G; Schwarz M; Tennekes H
Carcinog Compr Surv; 1982; 7():111-25. PubMed ID: 7039825
[No Abstract] [Full Text] [Related]
20. Properties of incomplete carcinogens and promoters in hepatocarcinogenesis.
Pitot HC; Goldsworthy T; Moran S; Sirica AE; Weeks J
Carcinog Compr Surv; 1982; 7():85-98. PubMed ID: 6802499
[No Abstract] [Full Text] [Related]
[Next] [New Search]
